Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study

Phua Kah Hing Ling; Fernando Civeira; Andrei Gheorghe Dan; Mary E Hanson; Rachid Massaad,; Celine Le Baill De Tilleghem; Christopher Milardo; Joseph Triscari

doi:10.1186/1476-511X-11-18

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study

Phua Kah Hing Ling
, Fernando Civeira
, Andrei Gheorghe Dan
, Mary E Hanson
, Rachid Massaad,
, Celine Le Baill De Tilleghem
, Christopher Milardo
, Joseph Triscari

Malaysia Jeffrey Cheah Sch of Med & HS

Research output: Contribution to journal › Article › Research › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	1 - 8
Number of pages	8
Journal	Lipids in Health and Disease
Volume	11
Issue number	Art. ID: 18
DOIs	https://doi.org/10.1186/1476-511X-11-18
Publication status	Published - 2012

Access to Document

10.1186/1476-511X-11-18

Cite this

Ling, P. K. H., Civeira, F., Dan, A. G., Hanson, M. E., Massaad, R., De Tilleghem, C. L. B., Milardo, C., & Triscari, J. (2012). Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study. Lipids in Health and Disease, 11(Art. ID: 18), 1 - 8. https://doi.org/10.1186/1476-511X-11-18

@article{75fb6d2380e442ffa4d3c5b4efe303c7,

title = "Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study",

author = "Ling, \{Phua Kah Hing\} and Fernando Civeira and Dan, \{Andrei Gheorghe\} and Hanson, \{Mary E\} and Rachid Massaad, and \{De Tilleghem\}, \{Celine Le Baill\} and Christopher Milardo and Joseph Triscari",

year = "2012",

doi = "10.1186/1476-511X-11-18",

language = "English",

volume = "11",

pages = "1 -- 8",

journal = "Lipids in Health and Disease",

issn = "1476-511X",

publisher = "BioMed Central",

number = "Art. ID: 18",

}

Ling, PKH, Civeira, F, Dan, AG, Hanson, ME, Massaad, R, De Tilleghem, CLB, Milardo, C & Triscari, J 2012, 'Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study', Lipids in Health and Disease, vol. 11, no. Art. ID: 18, pp. 1 - 8. https://doi.org/10.1186/1476-511X-11-18

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study. / Ling, Phua Kah Hing; Civeira, Fernando; Dan, Andrei Gheorghe et al.
In: Lipids in Health and Disease, Vol. 11, No. Art. ID: 18, 2012, p. 1 - 8.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study

AU - Ling, Phua Kah Hing

AU - Civeira, Fernando

AU - Dan, Andrei Gheorghe

AU - Hanson, Mary E

AU - Massaad,, Rachid

AU - De Tilleghem, Celine Le Baill

AU - Milardo, Christopher

AU - Triscari, Joseph

PY - 2012

Y1 - 2012

UR - http://www.lipidworld.com/content/pdf/1476-511X-11-18.pdf

U2 - 10.1186/1476-511X-11-18

DO - 10.1186/1476-511X-11-18

M3 - Article

SN - 1476-511X

VL - 11

SP - 1

EP - 8

JO - Lipids in Health and Disease

JF - Lipids in Health and Disease

IS - Art. ID: 18

ER -

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study

Access to Document

Other files and links

Cite this